Locations
 
WEBSITES
  • United States (English)
  • International (English)
  • Chinese (中文)
  • French (Français)
  • German (Deutsch)
  • Italian (Italiano)
  • Japanese (日本語)
  • Russian (Русский)
  • Whole Blood Technologies
 

Leaving U.S. website

You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

YesNo
  • Investor Relations
  • PORTALS
    • IMPACT Online
    • HaemoLink™
  • LOGIN
    • Haemonetics
    • HSS Client Login
    • IMPACT Online
    • Software Download Center
  • REGISTER
  • Home
  • Products
     
    U.S. ProductsView International Products View U.S. Whole Blood Technologies
    Devices
    Surgical and Diagnostic Devices
    • Cell Saver Elite+
    • Cell Saver 5+
    • Cell Saver Elite
    • OrthoPAT
    • SmartSuction Harmony
    • TEG
    Blood and Plasma Center Devices
    • ACP 215
    • MCS+ 8150
    • MCS+ 9000
    • NexSys PCS®
    • PCS 2
    Software
    Blood Center Software
    • Donor Doc
    • eDonor
    • ElDorado Donor
    • Hemasphere
    • Surround
    Hospital Software
    • BloodTrack
    • EdgeCell
    • SafeTrace Tx
    Plasma Center Software
    • Cash Card Software
    • DMS
    • NextGen
    Services
    Consulting Services
    • Education and Change Management
    • Process Improvement
    Software Services
    • Software Services Overview
    • Client Support
    • Education Services
    • Implementation Services
    • Technical Services
    • Validation Services
    • Software Solutions Partners
     
  • Solutions
     
    Blood Management Solutions
    • Solutions for Blood Centers
    • Solutions for Hospitals
    • Solutions for Plasma Centers
    • Software Solutions
    • Donor Process Automation
     
  • Learning Center
     
    Product Training
    • All Products
    • Blood Centers
    • Hospitals
    • Plasma Centers
    Thought Leadership
    • White Papers & Clinical Reviews
    • Reference Lists
    • Poster Abstracts
    Education
    • Presentations
     
  • About Haemonetics
     
    Company Background
    • Overview
    • Historical Timeline
    • Leadership Team
    • Scientific Advisory Council

    • Office Locations
    Investor Relations
    • Investor Relations Home
    • Stock Information
    • Earnings
    • Forecasts & Guidance
    News & Events
    • In the News
    • Calendar of Events
    • Publications
    Careers
    • Careers Overview
    • Employee Spotlights
    • Open Positions

    Grants

    • Grant Program

     
  • Customer Support

Leaving U.S. website

You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

YesNo
  • Home
  • Learning Center
  • Thought Leadership
  • White Papers & Clinical Reviews
  • Contact Us
  • Print
  • Share

White Papers & Clinical Reviews

  • FOCUS Trial
  • FOCUS Trial - Functional outcomes in cardiovascular patients undergoing surgical repair of hip fracture

    Clinical Review: N Engl J Med 2011; 365:2453-62

    Conclusion: A liberal transfusion strategy, as compared with a restrictive strategy, did not reduce rates of death or inability to walk independently on 60-day follow-up or reduce in-hospital morbidity in elderly patients at high cardiovascular risk.
    View document
  • Anemia and the Perioperative Patient

    White Paper by M. Popovsky, M.D., R. Thurer, M.D., P. Parce, RN

    Excerpt: Anemia is a remarkably prevalent condition. Forty percent of patients presenting with hip fracture and 38% of acutely admitted geriatric patients have anemia (5). Studies of critically ill patients found that 77% experience anemia in the ICU. Sixty three percent of these patients had hemoglobin values less than 12 g/dL and 29% less than 10g/dL. View document View reference list
  • Blood Management: State of the Art
    The Use of Red Blood Cells and Fresh Frozen Plasma

    White Paper by M. Popovsky, M.D., R. Thurer, M.D., P. Parce, RN

    Excerpt: Blood transfusion is an integral part of medical and surgical practice, and its safety is now assumed. Although the transmission of virus-borne diseases – such as HIV and hepatitis – by blood transfusion are extraordinarily rare events, blood should be viewed as a potent drug that entails significant risk.
    View document View reference list
  • The Pros and Cons of Preoperative Autologous Blood Donation

    White Paper by Mark A. Popovsky, M.D., Robert L. Thurer, M.D.

    Preoperative autologous blood donation (PABD) was once a powerful tool to decrease the risk of transfusion-transmitted disease related to allogeneic blood. With the development of effective viral screening tests and the recognition of the many disadvantages of stored blood, the need for and appropriateness of PABD has greatly diminished. There are now better and safer alternatives. The advantages and disadvantages of PABD are discussed in this review. View document
  • Contact Us
  • Terms of Use
  • Quality
  • Careers
  • Privacy Policy
  • Site Map

© 2011-2018 Haemonetics Corporation • 400 Wood Road • Braintree • MA • 02184